XML 66 R49.htm IDEA: XBRL DOCUMENT v3.25.0.1
Business Combination - Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
 12 Months Ended
May 24, 2022
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Business Acquisition [Line Items]        
Total purchase consideration, net of $46,548 cash acquired   $ 0 $ 0 $ 999,120
Liabilities        
Goodwill   $ 416,821 416,821  
Antares Pharma, Inc        
Business Acquisition [Line Items]        
Total purchase consideration, net of $46,548 cash acquired     999,120  
Cash acquired $ 46,548      
Assets        
Short-term investments     498  
Accounts receivable, net     81,960  
Inventories     28,068  
Prepaid expenses and other assets     5,241  
Property and equipment, net     28,661  
Intangibles, net     589,800  
Liabilities        
Accounts Payable     7,197  
Accrued expenses     43,692  
Deferred revenue, current portion     2,509  
Deferred revenue, net of current portion     1,207  
Deferred tax liabilities, net     76,536  
Other long-term liabilities     20,788  
Net assets acquired, excluding goodwill     582,299  
Goodwill     $ 416,821